Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Merus N.V. CS (MRUS)

Merus N.V. CS (MRUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period Business Wire - Fri Dec 12, 2025

Company Announcement Transaction adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio ...

GMAB : 33.75 (-1.78%)
MRUS : 90.00 (-7.14%)
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period GlobeNewswire - Fri Dec 12, 2025

Company Announcement Transaction adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolioTransaction...

GMAB : 33.75 (-1.78%)
MRUS : 90.00 (-7.14%)
0MGB.LN : 2,163.500 (-0.78%)
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-MRUS, ACLS, VECO, and CLCO PR Newswire - Fri Nov 21, 2025

NEW YORK , Nov. 21, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

VECO : 46.17 (-2.98%)
ACLS : 120.36 (-4.02%)
MRUS : 90.00 (-7.14%)
CLCO : 9.67 (unch)
Merus and Halozyme Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab PR Newswire - Mon Nov 17, 2025

SAN DIEGO and UTRECHT, The Netherlands and CAMBRIDGE, Mass. , Nov. 17, 2025 /PRNewswire/ -- Merus N.V.  (Nasdaq: MRUS) ("Merus"), an oncology company developing innovative, full-length multispecific...

MRUS : 90.00 (-7.14%)
HALO : 107.06 (-2.07%)
Halper Sadeh LLC Encourages HSII, MRUS, ATXS Shareholders to Contact the Firm to Discuss Their Rights PR Newswire - Wed Nov 12, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

ATXS : 12.58 (+0.64%)
MRUS : 90.00 (-7.14%)
HSII : 59.01 (+0.07%)
Halper Sadeh LLC Encourages TIPT, MRUS, PBBK Shareholders to Contact the Firm to Discuss Their Rights PR Newswire - Wed Nov 5, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

MRUS : 90.00 (-7.14%)
TIPT : 18.44 (+0.22%)
PBBK : 19.81 (-6.34%)
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate Merger - MRUS, HSII, PRO, and PBBK PR Newswire - Tue Nov 4, 2025

NEW YORK , Nov. 4, 2025 /PRNewswire/ --

MRUS : 90.00 (-7.14%)
HSII : 59.01 (+0.07%)
PRO : 23.25 (+0.04%)
PBBK : 19.81 (-6.34%)
Merus’ Interim Data on Petosemtamab in Metastatic Colorectal Cancer Demonstrates Monotherapy Activity and Robust Response Rate in Combination with FOLFOX/FOLFIRI with Well Tolerated Safety GlobeNewswire - Fri Oct 24, 2025

– 100% response rate in 1L left-sided mCRC (n=8, confirmed and unconfirmed) – 62% response rate in 2L left- and right-sided mCRC (n=13, confirmed and...

MRUS : 90.00 (-7.14%)
Merus Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS Business Wire - Thu Oct 23, 2025

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Merus N.V....

GMAB : 33.75 (-1.78%)
MRUS : 90.00 (-7.14%)
Halper Sadeh LLC Investigates FSFG, MTSR, VRNT, MRUS on Behalf of Shareholders PR Newswire - Tue Oct 21, 2025

NEW YORK , Oct. 21, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches...

MTSR : 70.50 (-0.35%)
MRUS : 90.00 (-7.14%)
VRNT : 20.51 (+1.33%)
FSFG : 33.98 (+2.88%)

Barchart Exclusives

Trump Made Big Trades in This Dividend Growth ETF. You Probably Shouldn’t. Barchart - 1 hour ago
On June 22, the portfolio executed a sale of VIG valued between $5 million and $25 million. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.